ExploreWatchlistsPricing
  1. JP-listed companies
  2. KAKEN PHARMACEUTIAL CO., LTD.
  3. Financials
  4. Net income

KAKEN PHARMACEUTIAL CO., LTD. (4521)

Market cap
¥191.8B
P/E ratio
68.7x
A Japanese pharmaceutical company that manufactures and sells medicines, medical devices, and agricultural chemicals while also operating real estate leasing.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndNet income (Million JPY)YoY (%)
Mar 31, 202513,945+73.77%
Mar 31, 20248,025+47.52%
Mar 31, 20235,440-43.03%
Mar 31, 20229,549-28.77%
Mar 31, 202113,405-30.80%
Mar 31, 202019,370+8.97%
Mar 31, 201917,775-6.66%
Mar 31, 201819,043-13.51%
Mar 31, 201722,017+4.13%
Mar 31, 201621,143+74.42%
Mar 31, 201512,122+29.03%
Mar 31, 20149,395+8.81%
Mar 31, 20138,634+8.63%
Mar 31, 20127,948

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat